Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects

Gastroenterology

Volumn 115, Issue 6, 1998, Pages 1335-1339

  Peghini, P L ^a   Katz, P O ^a   Castell, D O ^a  

^a ALLEGHENY UNIVERSITY HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HELICOBACTER PYLORI; HISTAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH PH;

EID: 0031787618     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70010-1     Document Type: Article

References (21)

1. PL Peghini PO Katz NA Bracy DO Castell Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors Am J Gastroenterol 93 1998 763 767
2. Katz PO, Anderson C, Khoury R, Castell DO. Gastroesophageal reflux is associated with nocturnal gastric acid breakthrough on proton pump inhibitors BID. Aliment Pharmacol Ther (in press).
3. PL Peghini PO Katz DO Castell Bedtime ranitidine decreases gastric acid secretion and eliminates esophageal acid exposure overnight in a patient with Barrett's esophagus taking omeprazole 20 mg BID (abstr) Am J Gastroenterol 92 1997 1723
4. B Kuo DO Castell Optimal dosing of omeprazole 40 mg daily: effects on gastric acid and esophageal pH and serum gastrin in healthy controls Am J Gastroenterol 91 1996 1532 1538
5. MA Mohiuddin KG Pursnani DA Katzka RM Gideon JA Castell DO Castell Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules Dig Dis Sci 42 1997 715 719
6. KG Pursnani MA Mohiuddin KR Geisinger G Weinbaum DO Castell Quantitative evaluation of the role of ‘acid burden’ in production of feline esophagitis (abstr) Gastroenterology 110 1996 A235
7. JG Moore E Englert Circadian rhythm of gastric acid secretion in man Nature 226 1970 1261 1262
8. JG Moore F Halberg Circadian rhythm of gastric acid secretion in men with active duodenal ulcer Dig Dis Sci 31 1986 1185 1191
9. E Levin JB Kirsner WL Palmer C Butler The variability and periodicity of the nocturnal gastric secretion in normal individuals Gastroenterology 10 1948 939 951
10. V Savarino GS Mela P Scalabrini A Sumberaz G Fera Celle G. 24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry Dig Sis Sci 33 1988 1077 1080
11. JG Moore M Wolfe The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man Digestion 9 1973 97 105
12. M Feldman CT Richardson Total 24 hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy Gastroenterology 90 1986 540 544
13. BI Hirschowitz D Keeling M Lewin S Okabe M Parsons K Sewing B Wallmark G Sachs Pharmacological aspects of acid secretion Dig Dis Sci 40 1995 3S 23S
14. J DelValle MR Lucey T Yamada Gastric secretion 2nd ed T Yamada Textbook of gastroenterology 1995 Lippincott Philadelphia 295 326
15. PJ Prichard ND Yeomans GW Mihaly DB Jones PJ Buckle RA Smallwood WJ Louis Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage Gastroenterology 88 1985 64 69
16. T Lind C Cederberg G Ekenved U Haglund L Olbe Effect of omeprazole—a gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man Gut 24 1983 270 276
17. C Cederberg T Andersson I Skanberg Omeprazole: pharmacokinetics and metabolism in man Scand J Gastroenterol 24 suppl 166 1989 33 40
18. JA Blair M Feldman C Barnett JH Walsh CT Richardson Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects J Clin Invest 79 1987 582 587
19. 2-receptor antagonist N Engl J Med 309 1983 1368 1373
20. JD Balian N Sukhova JW Harris J Hewett L Pickle JA Goldstein RL Woosley DA Flockhart The hydroxylation of omeprazole correlates with S -mephenytoin metabolism: a population study Clin Pharmacol Ther 57 1995 662 669
21. JS Marinac JD Balian JW Foxworth SK Willsie JC Daus R Owen DA Flockhart Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype Clin Pharmacol Ther 60 1996 138 144